Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | Director | Ordinary Shares | 5.23K | $569K | $108.83 | Aug 2, 2024 | Direct |
ANAPTYSBIO, INC | Director | Restricted Stock Unit | 3.9K | $85.1K | $21.81 | Jan 6, 2023 | Direct |
Y-mAbs Therapeutics, Inc. | Director | Common Stock | 5.83K | $69.9K | $12.00 | Jun 11, 2024 | Direct |
Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 250K | Jan 17, 2023 | Direct | ||
Y-mAbs Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 14.5K | Jun 11, 2024 | Direct | ||
ANAPTYSBIO, INC | Director | Stock Option (right to buy) | 10.6K | Jan 6, 2023 | Direct | ||
ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct | ||
PARDES BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 0 | Aug 31, 2023 | Direct |